Anti-CD200 Neutralizing Antibody

Quote the promo code SZANTIBODY when ordering to receive a 10% discount on this antibody, from October 1st to December 31st 2024. No additional discounts during the promo.

Products from BPS Bioscience require a minimum order value above 400€

Application: Useful for binding studies, and as a positive control in neutralization assays.

Assay Conditions: CD200/CD200R1 Neutralization Assay: This assay was performed following the protocol described in CD200:CD200R1 [Biotinylated] Inhibitor Screening Chemiluminescence Assay Kit (#82285) with increasing concentrations of Anti-CD200 Neutralizing Antibody. 

Background: CD200 (cluster of differentiation 200), also known as OX-2, is type 1 membrane glycoprotein of the immunoglobulin supergene family. It is structurally related to the B7 family of costimulatory receptors. It is found in cells of the myeloid and lymphoid lineage, such as activated T and B cells, neurons, endothelial cells, and cancer cells. Its expression depends on IFN-γ (interferon gamma) and TNF-α (tumor necrosis factor alpha), and it is regulated by C/EBP-β. When bound to CD200R (CD200 receptor) it contributes to the formation of an immunosuppressive TME (tumor microenvironment), via a Dok1 (docking protein 1), Dok2 and RasGAP dependent mechanism, leading to T cell responses inhibition, NK cell cytotoxicity decrease, potentiation of Treg cell expansion and decrease of other immune responses to cancer cells. CD200 can be found in a soluble form at high levels in the serum of cancer patients, linking to a poor prognosis. A splice variant missing exon 2, CD200tr, can also be formed, which may act as a competitive inhibitor for full length CD200. In addition to cancer, CD200 is linked to auto-immune disorders, inflammation, infection, and graft survival. Samalizumab, an anti-CD200 monoclonal antibody, has resulted in positive outcomes when used in patients suffering from CLL (chronic lymphocytic leukemia) and MM (multiple myeloma).

Description: This anti-CD200 (cluster of differentiation 200) neutralizing antibody is a purified, recombinant monoclonal antibody that recognizes human CD200. This antibody has been tested for specific binding to purified recombinant CD200.

Format: Aqueous buffer solution.

Formulation: 8 mM phosphate, pH 7.4, 110 mM NaCl, 2.2 mM KCl, and 20% glycerol

Host Cell Line: HEK293

Purity: ≥90%

Storage Stability: At least 12 months at -80°C.

Uniprot: P41217

Warnings: Avoid freeze/thaw cycles

Biosafety Level: Not applicable (BSL-1)

• Artikelnummer: BPS102062-2
• Hersteller: BPS Bioscience
• Hersteller Artikelnummer: 102062-2
• Verpackungseinheit: 100 µg
• Mengeneinheit: STK
• Klonalität: Monoclonal
• Isotyp: IgG1
• Wirt: Human
• Konjugat: Unconjugated